Ole Ahlehoff
- Internal Medicine top 0.5%
-
- Antiplatelet Therapy and Cardiovascular Diseases 12
- Atrial Fibrillation Management and Outcomes 9
- Acute Myocardial Infarction Research 9
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis 20
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 9
- Systemic Lupus Erythematosus Research 6
- Dermatology top 1%
-
- Health Systems, Economic Evaluations, Quality of Life 7
-
- Inflammatory Bowel Disease 6
- Co-authors
- Gunnar GislasonPeter Riis HansenJesper LindhardsenChristian Torp‐PedersenJonas Bjerring OlesenGregory Y.H. LipLone SkovJanne Schurmann Tolstrup
- Journals
- European Heart Journal (6 papers)PLoS ONE (5 papers)Journal of the European Academy of Dermatology and Venereology (4 papers)
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Ole Ahlehoff
65 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Internal Medicine 603
- Cardiology and Cardiovascular Medicine 2.1k
- Immunology 1.4k
- Rheumatology 964
- Dermatology 421
Countries citing papers authored by Ole Ahlehoff
This map shows the geographic impact of Ole Ahlehoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Ahlehoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Ahlehoff more than expected).
Fields of papers citing papers by Ole Ahlehoff
This network shows the impact of papers produced by Ole Ahlehoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Ahlehoff. The network helps show where Ole Ahlehoff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ole Ahlehoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 24 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 10 | |
| 5 | 2015 | 14 | |
| 6 | 2015 | 19 | |
| 7 | 2014 | 75 | |
| 8 | 2014 | 148 | |
| 9 | 2013 | 114 | |
| 10 | 2013 | 198 | |
| 11 | 2012 | 28 | |
| 12 | 2012 | 13 | |
| 13 | 2012 | 30 | |
| 14 | 2011 | 38 | |
| 15 | 2011 | 161 | |
| 16 | 2011 | 78 | |
| 17 | Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use | 2010 | 11 |
| 18 | 2010 | 359 | |
| 19 | 2010 | 1 | |
| 20 | 2010 | 2 |
About Ole Ahlehoff
Ole Ahlehoff is a scholar working on Cardiology and Cardiovascular Medicine, Immunology, Internal Medicine, Rheumatology and Dermatology, having authored 66 papers that have together received 4.6k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Atrial Fibrillation Management and Outcomes (9 papers), Acute Myocardial Infarction Research (9 papers), Rheumatoid Arthritis Research and Therapies (9 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Systemic Lupus Erythematosus Research (6 papers) and Inflammatory Bowel Disease (6 papers). The work is most often cited by research in Internal Medicine (603 citations), Cardiology and Cardiovascular Medicine (2.1k citations), Immunology (1.4k citations), Rheumatology (964 citations) and Dermatology (421 citations). Ole Ahlehoff has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Gunnar Gislason, Peter Riis Hansen, Jesper Lindhardsen, Christian Torp‐Pedersen, Jonas Bjerring Olesen, Gregory Y.H. Lip, Lone Skov, Janne Schurmann Tolstrup, Christian Selmer and C. Torp-Pedersen. Their work appears in journals such as European Heart Journal, PLoS ONE, Journal of the European Academy of Dermatology and Venereology, Journal of Internal Medicine and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.